Home

Preclinical

Bipolar, Schizophrenia

Read time: 3 min

Congress highlights

Debate continues on impact of duration of untreated psychosis on outcomes in psychosis

Duration of untreated psychosis (DUP) is defined as the time from manifestation of the first...

Read time: 6 min

Satellite symposium

Migraine control and the optimal treatment pathway

More than one billion individuals across the world are affected by migraine.1 Headache disorders,...

Alzheimer's Disease

Read time: 3 min

Satellite symposium

Neuroinflammation – why it matters in Alzheimer’s disease

Currently there are few options for the treatment of Alzheimer’s disease (AD), with...

Read time: 3 min

Congress highlights

Glutamate and Oxidative Stress: A novel approach to pathophysiology in schizophrenia

It is well accepted that a combination of genetic and environmental factors is implicated in the...

Read time: 4 min

Neuronal growth and plasticity is focus of top brain prize

Research on the regulation of proteins that underpin brain development and plasticity has won...

Alzheimer's Disease

Read time: 7 min

Tau neuropathology in Alzheimer’s disease and other neurodegenerative conditions

In this symposium titled ‘Human Neuropathology: Tau, a key protein in the human brain,...

Alzheimer's Disease

Read time: 4 min

Satellite symposium

Assessing clinical outcomes in Alzheimer’s disease

Clinical outcomes are vital to assess a person with Alzheimer’s disease (AD) and track their...

Medical education resource center

Lundbeck Institute Campus

The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind Israel
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in the Israel click here.

Already registered Register

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country